Inventor · disambiguated record
Joe Tran
Also filed as: TRAN JOE · TRAN JOE A · TRAN JOE ANH
12 granted patents·19 pending applications·472 citations·filing 2000–2024
90Inventor score
Files withVERTEX PHARMA10DART NEUROSCIENCE LLC6NEUROCRINE BIOSCIENCES INC5RAYZEBIO INC3UNIV CALIFORNIA2
Top patents by PatentIndex Score
31 records- 0198US6682938B1Glucose sensing molecules having selected fluorescent propertiesUNIV CALIFORNIA·Filed 2000·Granted Jan 27, 2004·244 cites·24 claims
- 0298US6673625B2Saccharide sensing molecules having enhanced fluorescent propertiesUNIV CALIFORNIA·Filed 2001·Granted Jan 6, 2004·195 cites·8 claims
- 0393US11414439B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Aug 16, 2022·6 cites·31 claims
- 0485US2025171469A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0584US8575177B2Pyrazolopyrimidines and related heterocycles as CK2 inhibitorsHADDACH MUSTAPHA·Filed 2010·Granted Nov 5, 2013·12 cites·40 claims
- 0682US11434247B1Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Granted Sep 6, 2022·2 cites·24 claims
- 0782US9303033B2Pyrazolopyrimidines and related heterocycles as CK2 inhibitorsSENHWA BIOSCIENCES INC·Filed 2013·Granted Apr 5, 2016·6 cites·44 claims
- 0878US11365191B2Substituted cyclohexyl compounds as NOP inhibiiorsDART NEUROSCIENCE LLC·Filed 2019·Granted Jun 21, 2022·2 cites·25 claims
- 0978US2025145633A1Substituted furanopyrimidine compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1077US2025092024A1Substituted cyclohexyl compounds as nop inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1176US2023312616A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1275US12006325B2Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Jun 11, 2024·0 cites·20 claims
- 1375US8367681B2Pyrazolopyrimidines and related heterocycles as kinase inhibitorsCYLENE PHARMACEUTICALS INC·Filed 2010·Granted Feb 5, 2013·3 cites·13 claims
- 1474US11945808B2Substituted cyclohexyl compounds as NOP inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Apr 2, 2024·0 cites·20 claims
- 1574US2025057997A1Conjugates comprising covalent binders for targeting intracellular proteinsRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 1674US2024342318A1Conjugates comprising covalent binders for targeting intracellular proteinsRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 1767US2021139514A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 1865US2025222146A1Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses ThereofRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 1961US2025122218A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2060US2025388541A1Heteroaryl compounds for the treatment of painVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2159US8481731B2Compounds, pharmaceutical composition and methods relating theretoTRAN JOE A·Filed 2010·Granted Jul 9, 2013·1 cites·22 claims
- 2259US8293729B2Compounds, pharmaceutical composition and methods relating theretoDYCK BRIAN·Filed 2010·Granted Oct 23, 2012·1 cites·20 claims
- 2356US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2456US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2556US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2656US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2746US2005119252A1Ligands of melanocortin receptors and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 2842US2003158209A1Ligands of melanocortin receptors and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2002·Application pending·0 cites
- 2941US2005192286A1Ligands of melanocortin receptors and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 3040US2004192676A1Ligands of melanocortin receptors and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 3140US2004053933A1Ligands of melanocortin receptors and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joe Tran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →